Competition and natural selection in a mathematical model of cancer

被引:50
作者
Nagy, JD [1 ]
机构
[1] Scottsdale Community Coll, Dept Biol, Scottsdale, AZ 85256 USA
关键词
D O I
10.1016/j.bulm.2003.10.001
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
A malignant tumor is a dynamic amalgamation of various cell phenotypes, both cancerous (parenchyma) and healthy (stroma). These diverse cells compete over resources as well as cooperate to maintain tumor viability. Therefore, tumors are both an ecological community and an integrated tissue. An understanding of how natural selection operates in this unique ecological context should expose unappreciated vulnerabilities shared by all cancers. In this study I address natural selection's role in tumor evolution by developing and exploring a mathematical model of a heterogenous primary neoplasm. The model is a system of nonlinear ordinary differential equations tracking the mass of up to two different parenchyma cell types, the mass of vascular endothelial cells from which new tumor blood vessels are built and the total length of tumor microvessels. Results predict the possibility of a hypertumor-a focus of aggressively reproducing parenchyma cells that invade and destroy part or all of the tumor, perhaps before it becomes a clinical entity. If this phenomenon occurs, then we should see examples of tumors that develop an aggressive histology but are paradoxically prone to extinction. Neuroblastoma, a common childhood cancer, may sometimes fit this pattern. In addition, this model suggests that parenchyma cell diversity can be maintained by a tissue-like integration of cells specialized to provide different services. (C) 2003 Society for Mathematical Biology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:663 / 687
页数:25
相关论文
共 36 条
[11]  
Ganong W.F., 1999, Review of Medical Physiology
[12]   Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours [J].
Graeber, TG ;
Osmanian, C ;
Jacks, T ;
Housman, DE ;
Koch, CJ ;
Lowe, SW ;
Giaccia, AJ .
NATURE, 1996, 379 (6560) :88-91
[13]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[14]   Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF [J].
Holash, J ;
Maisonpierre, PC ;
Compton, D ;
Boland, P ;
Alexander, CR ;
Zagzag, D ;
Yancopoulos, GD ;
Wiegand, SJ .
SCIENCE, 1999, 284 (5422) :1994-1998
[15]  
HORN L, 1988, VASCULAR ENDOTHELIUM, P35
[16]   Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: Role of vascular endothelial growth factor [J].
Jain, RK ;
Safabakhsh, N ;
Sckell, A ;
Chen, Y ;
Jiang, P ;
Benjamin, L ;
Yuan, F ;
Keshet, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10820-10825
[17]  
KITANAKA C, 2002, J NATL CANCER I, V94, P319
[18]  
KRAGGERUD SM, 1995, ANTICANCER RES, V15, P683
[19]   Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo [J].
Lobov, IB ;
Brooks, PC ;
Lang, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) :11205-11210
[20]  
Loeb LA, 1996, CANCER SURV, V28, P329